You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

THERMAZENE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Thermazene patents expire, and when can generic versions of Thermazene launch?

Thermazene is a drug marketed by Thepharmanetwork Llc and is included in one NDA.

The generic ingredient in THERMAZENE is silver sulfadiazine. There are twenty-two drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.

Summary for THERMAZENE
Drug patent expirations by year for THERMAZENE
Recent Clinical Trials for THERMAZENE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
OHSU Knight Cancer InstituteN/A
Oregon Health and Science UniversityN/A

See all THERMAZENE clinical trials

Pharmacology for THERMAZENE

US Patents and Regulatory Information for THERMAZENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Thepharmanetwork Llc THERMAZENE silver sulfadiazine CREAM;TOPICAL 018810-001 Dec 23, 1985 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.